Guerbet SA (EPA:GBT)
France · Delayed Price · Currency is EUR 6.68
-0.03 (-0.45%)
Oct 2, 2026, 5:35 PM CET
Guerbet Market Cap
Guerbet has a market cap or net worth of €84.65 million as of October 2, 2026. Its market cap has decreased by -50.61% in one year.
Market Cap
84.65M
Enterprise Value
403.43M
Revenue
790.65M
Ranking
n/a
PE Ratio
n/a
Stock Price
€6.68
ChartMarket Cap Chart
Since March 3, 1992, Guerbet's market cap has decreased from 142.85M to 84.65M, a decrease of -40.74%. That is a compound annual growth rate of -1.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 84.65M | -53.02% |
| Dec 31, 2025 | 180.20M | -46.68% |
| Dec 31, 2024 | 337.92M | 37.29% |
| Dec 29, 2023 | 246.14M | 14.95% |
| Dec 30, 2022 | 214.13M | -54.42% |
| Dec 31, 2021 | 469.83M | 13.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Carvolix | 342.43M |
| Eurobio Scientific Société anonyme | 252.71M |
| Median Technologies | 143.12M |
| Theraclion | 50.74M |
| Novacyt | 35.89M |
| Mauna Kea Technologies | 27.00M |
| Diagnostic Medical Systems | 23.48M |
| Implanet | 23.01M |